Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Fig. 1

Patient cohorts. A total of 138 NSCLC patients harboring MET tyrosine kinase domain (TKD) mutations were included in the study cohort. After excluding patients without paired samples, 86 MET TKD mutation-positive patients were included in the final analysis, which was subdivided into three cohorts: baseline (N = 32), MET-TKI-treated (N = 41), and EGFR-TKI-treated (N = 13)

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us